SCM
RVMD icon

Sterling Capital Management’s Revolution Medicines RVMD Stock Holding History

Sterling Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
5,685
-5,658
-50% -$826K 0.02% 528
2026
Q1 		$1.1M Sell
11,343
-9,926
-47% -$1M 0.02% 466
2025
Q4 		$1.69M Buy
21,269
+10,553
+98% +$692K 0.03% 452
2025
Q3 		$500K Sell
10,716
-820
-7% -$32.1K 0.01% 933
2025
Q2 		$426K Buy
11,536
+10,399
+915% +$399K 0.01% 991
2025
Q1 		$40.2K Sell
1,137
-819
-42% -$33.2K ﹤0.01% 1474
2024
Q4 		$85.6K Buy
1,956
+1,672
+589% +$84.4K ﹤0.01% 1480
2024
Q3 		$12.9K Buy
+284
New +$12.4K ﹤0.01% 1515

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Sterling Capital Management's RVMD Position: Q2 2026 in Review

Sterling Capital Management reduced its Revolution Medicines (RVMD) stake by 50% in Q2 2026, selling an estimated $826K and leaving 5,685 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #528.

Sterling Capital Management first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.69M in Q4 2025. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Sterling Capital Management held 5,685 shares of Revolution Medicines worth $1.06M as of Q2 2026.
  • Sterling Capital Management sold 5,658 Revolution Medicines shares in Q2 2026, an estimated $826K.
  • Revolution Medicines made up 0.02% of Sterling Capital Management's portfolio in Q2 2026, its #528 holding.
  • Sterling Capital Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Revolution Medicines position peaked at $1.69M in Q4 2025.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.